alexa The Role of Psychiatric Drugs and their Minimal-Medicat
ISSN: 2378-5756

Journal of Psychiatry
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

The Role of Psychiatric Drugs and their Minimal-Medication Alternatives in the Treatment of Schizophrenia

Megan Buoey*

Lancaster University, Lancashire, England, UK

*Corresponding Author:
Megan Buoey
Lancaster University
Lancashire, England, UK
Tel: +44 1524 65201
E-mail: [email protected]

Received Date: September 06, 2015; Accepted Date: December 13, 2016; Published Date: December 20, 2016

Citation: Buoey M (2016) The Role of Psychiatric Drugs and their Minimal- Medication Alternatives in the Treatment of Schizophrenia. J Psychiatry 20: 395 doi:10.4172/2378-5756.1000395

Copyright: © 2016 Buoey M. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited



Throughout this report I will be discussing reasons why our current psychiatric system needs improvements concerning the use of psychiatric drugs and how they may not be the answer to the symptoms of schizophrenia. This is an important topic to study considering the health dangers that patients are faced with today as a result of their illness and the medication used for it. I have researched the high success rates of alternative, minimum medication programmes, like open dialogue, which have greater focus on psychotherapies, as opposed to antipsychotic drugs. I have discussed the fundamental flaws with our accepted ideas of schizophrenia, and the implications this neurobiological research has for treatments. I have highlighted the problems with the psychiatric pharmaceutical industry, (particularly drug trials) which markets drugs in a misleading way, creating a paradigm where psychiatrists rely heavily on antipsychotics to stabilise their patients. This is not the best solution for the long term health of patients. I have concluded in this report that improvements to our system through increased integration of psychotherapies and lower dosages of psychiatric drugs, would greatly impact the quality of treatment that schizophrenic patients receive.


Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version